BioGaia AB Revenue vs. Price To Book
| BIOG-B Stock | SEK 107.00 1.70 1.61% |
For BioGaia AB profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioGaia AB to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioGaia AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioGaia AB's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioGaia AB over time as well as its relative position and ranking within its peers.
BioGaia |
BioGaia AB Price To Book vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioGaia AB's current stock value. Our valuation model uses many indicators to compare BioGaia AB value to that of its competitors to determine the firm's financial worth. BioGaia AB is the top company in revenue category among its peers. It also is number one stock in price to book category among its peers . The ratio of Revenue to Price To Book for BioGaia AB is about 231,229,290 . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioGaia AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioGaia AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BioGaia Revenue vs. Competition
BioGaia AB is the top company in revenue category among its peers. Market size based on revenue of Drug Manufacturers - Specialty & Generic industry is currently estimated at about 1.11 Billion. BioGaia AB totals roughly 1.1 Billion in revenue claiming about 100% of equities under Drug Manufacturers - Specialty & Generic industry.
BioGaia Price To Book vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
BioGaia AB |
| = | 1.1 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
BioGaia AB |
| = | 4.77 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
BioGaia Price To Book Comparison
BioGaia AB is currently under evaluation in price to book category among its peers.
BioGaia AB Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioGaia AB, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioGaia AB will eventually generate negative long term returns. The profitability progress is the general direction of BioGaia AB's change in net profit over the period of time. It can combine multiple indicators of BioGaia AB, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden. BioGaia AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 144 people.
BioGaia Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioGaia AB. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioGaia AB position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioGaia AB's important profitability drivers and their relationship over time.
Use BioGaia AB in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioGaia AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioGaia AB will appreciate offsetting losses from the drop in the long position's value.BioGaia AB Pair Trading
BioGaia AB Pair Trading Analysis
The ability to find closely correlated positions to BioGaia AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioGaia AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioGaia AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioGaia AB to buy it.
The correlation of BioGaia AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioGaia AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioGaia AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioGaia AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioGaia AB position
In addition to having BioGaia AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Currency Funds Thematic Idea Now
Currency Funds
Funds or Etfs investing in a single currency or combination of currencies from different countries in order to replicate respective foreign exchange markets. The Currency Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Currency Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BioGaia Stock
To fully project BioGaia AB's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BioGaia AB at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BioGaia AB's income statement, its balance sheet, and the statement of cash flows.